Tekbeiri subcutaneous injection 153mg (Teclistamab), from Janssen Pharmaceutical (YJ code: 4291475A2020, standard: 153mg 1.7mL bottle), is a bispecific T-cell engager antibody. It is used for adults with relapsed or refractory multiple myeloma by engaging T-cells to target BCMA-expressing cancer cells.
Tekbeiri subcutaneous injection 153mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →